Ongoing symptoms that persist despite treatment can disrupt daily life, work, and mental well-being among adults with generalized myasthenia gravis (gMG), according to the BEYOND study. When study participants rated how strongly they agreed with statements about how these ongoing symptoms affect their everyday lives, the statement — “If…
News
Biologic therapies were associated with less steroid use and greater muscle strength than treatment with standard care among people recovering from a myasthenic crisis, a potentially life-threatening complication of myasthenia gravis (MG), a new study from China suggests. Data showed that six months after leaving the hospital, individuals…
The Myasthenia Gravis News forums welcomed Jenny McCue, vice president of research and clinical development at the Myasthenia Gravis Foundation of America (MGFA), for an hour-long Q&A earlier this month. Forum members had an opportunity to ask questions in real time about the latest in myasthenia gravis…
Most neurologists believe that CAR T-cell treatments have the potential to revolutionize care for neuro-immune diseases such as myasthenia gravis (MG), but hopes are tempered by still-unanswered questions about their safety and long-term impact. That’s according to a survey of 92 neurologists in the U.S. conducted last month by…
Myasthenia gravis (MG) can have a substantial impact on a person’s quality of life, but currently available data make it hard to nail down a number that can represent the average impact of the disease in standard health economic models, a review study showed. Score estimates in the EuroQol…
Adults with late-onset myasthenia gravis (LOMG), when symptoms begin at age 50 or later, showed advanced fatty replacement of the thymus gland, while a separate group of LOMG patients showed reduced production of new immune cells, according to a new study. Abnormalities in the thymus gland are well established…
Myasthenia gravis (MG) is associated with substantial disruptions to employment, with only about half of working-age adults with MG in a Spanish study employed and nearly one-third receiving permanent work disability benefits. Among participants who reported how MG had affected their employment, more than four in 10 said they…
Myasthenia gravis (MG) may be driven by antibody-producing immune B-cells going rogue in the thymus gland and developing escape mechanisms that allow them to attack the body’s own healthy tissues, according to new research by U.S. scientists. “Our study suggests there’s more to myasthenia gravis than antibodies alone,” Ankit…
Uplizna (inebilizumab) reduced the frequency of disease exacerbations, or periods when symptoms worsen, and the need for rescue therapy in people with generalized myasthenia gravis (gMG). That’s according to a prespecified analysis of data from the global Phase 3 MINT clinical trial (NCT04524273), which showed that after…
Myasthenia gravis (MG) is the strongest predictor of complications after a thymectomy, a surgery to remove a tumor of the thymus gland, according to a study in China. The risk of post-surgery complications was more than seven times higher in people with MG. Other factors independently associated with complication…
Recent Posts
- Targeted cell therapy shows promise in lab, mouse models of MG
- Thymectomy benefits older gMG patients without a thymus tumor
- Advocate For Yourself, Then Go Live: Jayna’s gMG Story
- Pacing myself for one event quietly erased everything else
- Ultomiris lifts quality of life, easing fatigue and brain fog in small study